Remington: The Science and Practice of Pharmacy
| [0023]
|
Introduction to Nanoscience and Nanotechnology
| [0023]
|
Dictionary of Microbiology and Molecular Biology
| [0023]
|
March's Advanced Organic Chemistry Reactions, Mechanisms and Structure
| [0023]
|
Dictionary of DNA and Genome Technology
| [0023]
|
Molecular Cloning: A Laboratory Manual
| [0023]
|
Antibodies A Laboratory Manual
| [0023]
|
Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion
| [0023]
|
Reshaping human antibodies for therapy
| [0023]
|
The 5-Minute Pediatric Consult
| [0024]
|
The Harriet Lane Handbook: A Manual for Pediatric House Officers
| [0024]
|
Current Diagnosis and Treatment in Pediatrics (Current Pediatrics Diagnosis & Treatment)
| [0024]
|
Int J Pept Protein Res.
| [0056]
|
J. Chem. Soc. Perkin Trans.
| [0056]
|
Biochemistry
| [0060]
|
Drug Latentiation
| [0069]
|
Application of Physical Organic Principles to Prodrug Design
| [0069]
|
Bioreversible Carriers in Drug in Drug Design, Theory and Application
| [0069]
|
Design of Prodrugs
| [0069]
|
Prodrug approaches to the improved delivery of peptide drug
| [0069]
|
Improvement in peptide bioavailability: Peptidomimetics and Prodrug Strategies
| [0069]
|
The Use of Esters as Prodrugs for Oral Delivery of (3-Lactam antibiotics
| [0069]
|
Designing Prodrugs and Bioprecursors I. Carrier Prodrugs
| [0069]
|
Improving Oral Drug Transport
| [0069]
|
Prodrugs for the improvement of drug absorption via different routes of administration
| [0069]
|
Involvement of multiple transporters in the oral absorption of nucleoside analogues
| [0069]
|
Fosphenytoin (Cerebyx)
| [0069]
|
Bioreversible derivatization of drugs-principle and applicability to improve the therapeutic effects of drugs
| [0069]
|
Improved drug delivery by the prodrug approach
| [0069]
|
Prodrugs as a means to improve the delivery of peptide drugs
| [0069]
|
Improved oral drug delivery: solubility limitations overcome by the use of prodrugs
| [0069]
|
Design of prodrugs for improved gastrointestinal absorption by intestinal enzyme targeting
| [0069]
|
Biologically Reversible Phosphate-Protective Groups
| [0069]
|
Bioreversible Protection for the Phospho Group: Chemical Stability and Bioactivation of Di(4-acetoxy-benzyl) Methylphosphonate with Carboxyesterase
| [0069]
|
Prodrugs of phosphates and phosphonates: Novel lipophilic alphaacyloxyalkyl ester derivatives of phosphate- or phosphonate containing drugs masking the negative charges of these groups
| [0069]
|
Pro-drug, molecular structure and percutaneous delivery
| [0069]
|
Penicillins: a current review of their clinical pharmacology and therapeutic use
| [0069]
|
Prodrugs of anticancer agents
| [0069]
|
Prodrugs. Do they have advantages in clinical practice?
| [0069]
|
Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics
| [0069]
|
Improved passive oral drug delivery via prodrugs
| [0069]
|
Prodrug strategies to enhance the intestinal absorption of peptides
| [0069]
|
Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection
| [0069]
|
Prodrugs
| [0069]
|
Retroviruses: Molecular Biology, Genomics and Pathogenesis
| [0076]
|
Pharmacological Reviews
| [0076]
|
J. Virol.
| [0077]
|
J. Virol.
| [0077]
|
Human Gene Therapy
| [0077]
|
J. Virol.
| [0077]
|
Gene Therapy
| [0077]
|
BioTechniques
| [0077]
|
Human Gene Therapy
| [0077]
|
Anesthes.
| [0077]
|
Clin. Genet.
| [0077]
|
Curr. Opin. Mol. Ther.
| [0077]
|
J. Biol. Chem.
| [0080]
|
Proc. Natl. Acad. Sci. USA
| [0080]
|
J. Virol.
| [0080]
|
J Cell Biol
| [0081]
|
Curr Biol.
| [0081]
|
Biochem. J.
| [0081]
|
Gene Transfer into Mouse Lyoma Cells by Electroporation in High Electric Fields
| [0083]
|
Electric Field Mediated Gene Transfer
| [0083]
|
Enhancer-dependent Expression of Human Kappa Immunoglobulin Genes Introduced into Mouse pre-B Lymphocytes by Electroporation
| [0083]
|
Molecular Cloning: A Laboratory Manual
| [0083]
|
Liposome-mediated Delivery of Tobacco Mosaic Virus RNA into Tobacco Protoplasts: A Sensitive Assay for Monitoring Liposome-protoplast Interactions
| [0083]
|
Biotherapy
| [0084]
|
Vaccine Design
| [0084]
|
Nature Medicine
| [0084]
|
Adoptive transfer of virus-specific and tumor-specific T cell immunity
| [0085]
|
Polymersomes: A new multi-functional tool for cancer diagnosis and therapy
| [0088]
|
Gold nanoparticles as novel agents for cancer therapy
| [0088]
|
Principles of Cancer Management: Radiation Therapy
| [0102]
|
Pharmaceuticals
| [0107]
|
Molecular Cloning: A Laboratory Manual
| [0109]
|
Methods in Enzymology
| [0109]
|
Gene Expression Technology: Methods in Enzymology
| [0109]
|
Vectors used for expression in mammalian cells
| [0111]
|
BioTechnique
| [0112]
|
Proc. Natl. Acad. Sci. USA
| [0112]
|
Focus
| [0112]
|
Proc. West. Pharmacol. Soc.
| [0112]
|
Remington: The Science and Practice of Pharmacy
| [0120]
|
Ann. Rev. Pharmacol. Toxicol.
| [0125]
|
Controlled Release of Pesticides and Pharmaceuticals
| [0125]
|
J. Pharm. Res.
| [0131]
|
J. Int. J. Pharm.
| [0131]
|
Aerosols for delivery of therapeutic an diagnostic agents to the respiratory tract
| [0131]
|
Am. Rev. Respir. Dis.
| [0131]
|
Advanced Drug Delivery Reviews
| [0131]
|
Int. J. Pharm.
| [0131]
|
Spray Technol. Market
| [0131]
|
Aerosol Sci.
| [0131]
|
Powder Technology
| [0131]
|
J. Controlled Release
| [0131]
|
Biomed. Mater. Res.
| [0131]
|
Drug Delivery
| [0131]
|
Adv. Drug Del. Rev.
| [0131]
|
Adv. Drug. Del. Rev.
| [0131]
|
Controlled Release
| [0131]
|
Nature Biotechnology
| [0131]
|
Pharm. Res.
| [0131]
|
Pharm. Res.
| [0131]
|
Drug Stability: Principles & Practice
| [0132]
|
Controlled Release Dosage Form Design
| [0133]
|
Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses
| [0148]
|
Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis
| [0150]
[0156]
|
Carbon monoxide-based therapy ameliorates acute pancreatitis via TLR4 inhibition
| [0150]
[0153]
[0156]
|
Models of acute and chronic pancreatitis
| [0150]
|
Myeloid, but not pancreatic, RelA/p65 is required for fibrosis in a mouse model of chronic pancreatitis
| [0150]
|
Identification, culture, and characterization of pancreatic stellate cells in rats and humans
| [0156]
[0156]
|
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture
| [0156]
|
Isolation and differentiation of monocytes-macrophages from human blood
| [0156]
|
Gastroenterology
| [0159]
|
Gastroenterology
| [0159]
|
Gastroenterology
| [0159]
[0173]
|
Gastroenterology
| [0159]
|
J. Clin. Invest.
| [0160]
|
J. Exp. Med.
| [0161]
|
Gastroenterology
| [0162]
|
Nat. Immunol.
| [0162]
|
J. Leukoc. Biol
| [0164]
|
Immunity
| [0164]
|
J. Clin. Invest.
| [0165]
[0178]
|
Nat. Rev. Immunol.
| [0165]
|
J. Clin. Invest.
| [0167]
[0175]
|
Nature
| [0169]
[0170]
|
Immunity
| [0170]
|
J. Gastroenterol. Hepatol.
| [0173]
|
Semin. Liver Dis.
| [0174]
|
Nat. Rev. Immunol.
| [0175]
|
Exerc. Immunol. Rev.
| [0175]
[0176]
|
Gut
| [0175]
|
Am. J. Pathol.
| [0175]
|
J. Immunol.
| [0176]
|
J. Leukoc. Biol.
| [0176]
|
Clin. Exp. Immunol.
| [0176]
|
Nat. Rev. Immunol.
| [0176]
|
Annu. Rev. Immunol.
| [0176]
|
Cancer Res.
| [0178]
|
Cancer Res.
| [0178]
|